Close
Nordic 9Nordic 9

SignaCor Therapeutics (private company)

United Kingdom
See something wrong or missing? Let us know
Offices:Belfast
Industry:Health servicesPharma
Business model:B2B

SignaCor Therapeutics is a British startup working on a treatment designed to repair heart damage and slow the progression of hypertrophic cardiomyopathy.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 1.3M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to SignaCor Therapeutics

Name Criteria
Iceland 3Z Pharmaceuticals
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France ABC Transfer
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Athera
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden AttgeNO
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Denmark Oui
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Ilya Pharma
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Spain Origo Biopharma
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Pharmanest
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France Pharmedigroup
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Belgium Pharmony
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Top